射频美容仪再获2年窗口期？国家药监局披露新规

China's National Medical Products Administration (NMPA) has extended the transition period for radiofrequency (RF) beauty devices to April 1, 2026, clarifying management requirements and operational details.

1. New Rule Effective Date: Starting April 1, 2026, RF therapy and skin treatment devices must obtain medical device registration certificates. Production, import, and sales of unregistered products will be prohibited.

2. Transition Arrangements: Existing Class II medical device registrations remain valid until expiration and can be extended by the original approval authority, with a maximum extension to March 31, 2026.

3. Corporate Responsibilities: Companies bear primary responsibility for product quality and must avoid false advertising. Non-medical devices cannot imply medical uses in names or intended purposes to prevent consumer confusion.

4. Industry Response: Beauty device brands have removed RF products from all sales channels and launched new non-RF technology products in response to the policy.

5. Background: A 2022 announcement originally classified these products as Class III medical devices with a 2024 effective date. The extension addresses challenges faced by handheld device manufacturers (mostly home appliance companies) due to pandemic disruptions and extended registration preparation timelines.

The new regulations impact brand R&D and marketing strategies, requiring adjustments based on shifting consumer trends.

1. Marketing Compliance: Brands must ensure promotional content is truthful and compliant. Non-RF products cannot use medical terminology or imply medical uses to avoid confusion.

2. Product Development: Brands are pivoting to develop non-RF technology products as replacements for RF beauty devices, creating innovation opportunities.

3. Consumer Trends: User behavior may shift toward non-RF devices. Brands can launch new products aligned with this demand change.

4. Channel Optimization: RF product removals necessitate adjustments to online/offline sales channels and inventory management.

5. Market Response: Leading brands indicate they are digesting policy implications, highlighting the need for rapid regulatory adaptation to maintain consumer trust.

Policy interpretation and strategic responses for sellers, with risk and opportunity analysis.

1. Policy Overview: The RF beauty device transition period extends to April 1, 2026. Sales of unregistered products are banned; certified products may apply for extensions.

2. Action Steps: Sellers should delist RF products and promote non-RF alternatives to mitigate legal risks. Observe leading brands' adaptation strategies.

3. Risk Management: Penalties apply for selling unregistered RF devices; avoid false advertising or medical use implications.

4. Opportunities: Growing non-RF beauty device market presents new sales prospects. Regulatory guidance and training support seller compliance efforts.

5. Best Practices: Industry-wide product delisting and new launches offer models for inventory and partnership restructuring.

New regulations require production adaptation and present commercial opportunities.

1. Production Compliance: RF beauty device manufacturing requires medical device registration. Factories, especially handheld device producers, face extended registration timelines due to pandemic impacts.

2. Market Opportunities: Rising demand for non-RF beauty devices creates openings for new product development.

3. Operational Optimization: Registration involves product testing and clinical evaluation. Digital management can streamline documentation. E-commerce shifts toward non-RF products create new online sales channels.

Industry trends highlight client pain points and solution opportunities.

1. Regulatory Evolution: RF beauty devices' transition to Class III medical device management reflects extended industry standardization through 2026.

2. Client Challenges: Home appliance manufacturers face prolonged registration processes due to pandemic disruptions and extended testing/clinical trial requirements.

3. Support Services: Regulatory authorities will provide targeted guidance on performance verification, testing, and clinical evaluation. Service providers can assist with registration preparation and documentation.

Platforms must address commercial demands and operational management challenges.

1. Compliance Requirements: RF beauty devices require medical device registration for platform sales. Platforms must ensure merchant product legality.

2. Current Actions: Platforms have delisted RF products and promoted non-RF alternatives in policy response. Leading brands' reactions indicate need for rapid listing strategy adjustments.

3. Risk Management: Strengthen product reviews to prevent false advertising or medical implications. Avoid penalties for unregistered product sales.

4. Merchant Recruitment: Prioritize compliant sellers utilizing regulatory guidance. Expand partnerships based on non-RF product offerings.

Policy changes reveal industry shifts and research implications.

1. Regulatory Adaptation: Extended transition period to 2026 reflects policy adjustments accommodating enterprise preparedness gaps, particularly among handheld device manufacturers.

2. Implementation Challenges: Prolonged registration timelines due to pandemic and standardization factors expose industry transformation difficulties.

3. Policy Implications: Enterprises bear product quality responsibility while regulators provide guidance. Policies balance public safety with industrial development.

4. Business Model Innovation: Brands shifting to non-RF products demonstrate regulatory adaptation through business model innovation, as seen in leading brands' product replacements.